Summary
Unable to assess prescribing-information alignment because only section 3 (dosage forms/strengths) was provided; all medical indications and usage claims cannot be verified against the supplied label text.
Category Scores
Accurate Statements
To verify the exact product tied to 'Proficient Rx LP,' check the prescription label or packaging for strength.
Section 3 text provided lists tablet strengths (25 mg, 50 mg, 100 mg), but the provided label text does not mention 'Proficient Rx LP' or the verification instruction itself.
To verify the exact product tied to 'Proficient Rx LP,' check the prescription label or packaging for dosage form.
Section 3 provided describes dosage form as tablets.
To verify the exact product tied to 'Proficient Rx LP,' check the prescription label or packaging for the manufacturer or 'distributed by' line.
No relevant label section text was provided regarding manufacturer/distributor identification.
To verify the exact product tied to 'Proficient Rx LP,' check the prescription label or packaging for the NDC (National Drug Code).
No relevant label section text was provided regarding NDC.
Spironolactone is a potassium-sparing diuretic.
No relevant section text provided (only section 3); therefore not verifiable against the supplied label text.
Spironolactone is used for heart failure.
No section 1 text provided; not verifiable.
Spironolactone is used for fluid retention.
No section 1 text provided; not verifiable.
Spironolactone is used for high blood pressure.
No section 1 text provided; not verifiable.
Spironolactone is used for hyperaldosteronism.
No section 1 text provided; not verifiable.
Spironolactone is used for certain hormone-related conditions in specific patient populations under medical supervision.
No section 1 text provided; not verifiable.
Unsupported Statements
Spironolactone is a potassium-sparing diuretic.
The only provided label section is 3 (Dosage Forms and Strengths); no definition/mechanism or class description is present in the supplied text.
Spironolactone is used for heart failure.
Indications (Section 1) are not included in the supplied label text.
Spironolactone is used for fluid retention.
Indications (Section 1) are not included in the supplied label text.
Spironolactone is used for high blood pressure.
Indications (Section 1) are not included in the supplied label text.
Spironolactone is used for hyperaldosteronism.
Indications (Section 1) are not included in the supplied label text.
Spironolactone is used for certain hormone-related conditions in specific patient populations under medical supervision.
This is an indications/specific populations claim requiring Section 1 (and potentially other sections); not present in supplied text.
To verify the exact product tied to 'Proficient Rx LP,' check the prescription label or packaging for the manufacturer or 'distributed by' line.
No label text was provided covering manufacturer/distributed-by information.
To verify the exact product tied to 'Proficient Rx LP,' check the prescription label or packaging for the NDC (National Drug Code).
No label text was provided covering NDC information.
Contradictions
Important Omissions
FDA-approved prescribing information for indications (Section 1) is not provided, preventing verification of multiple stated uses (heart failure, fluid retention, hypertension, hyperaldosteronism, and hormone-related conditions).
Importance:
High
Dosage and administration (Section 2) are not provided, so no verification of any dosing-related claims (if present) could be performed.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The response contains multiple unverified indication/classification statements because the supplied label text lacks Section 1 and related safety content. This creates compliance/accuracy risk, but no direct dosing or safety instructions were provided in the given claims.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Most medical claims (indications/class) are not supported by the supplied prescribing-information text (only Section 3 dosage form/strengths was provided).
Suggested Improvement
Provide and evaluate against the full FDA-approved label sections, especially Section 1 (Indications and Usage) and Section 2/4/5 as needed, then only restate claims that are explicitly supported by that label text.